Tindamax Tablet, Film Coated
Product Images NDC 0178-8250

4 FDA label images from Mission Pharmacal Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tindamax (NDC 0178-8250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mission Pharmacal Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C01 R0606 Tindamax 250mg 40cnt Rtl Lbl

C01 R0606 Tindamax 250mg 40cnt Rtl Lbl
Tindamax 250 mg tinidazole film-coated tablets label showing a 40-tablet count. The label includes storage instructions to keep at controlled room temperature (20-25°C), indicates prescription use only, and displays the NDC 0178-8250-40. Manufactured for Mission Pharmacal Company, the label also features a barcode and manufacturing details for Mikart Inc.*
FDA Label Image

Tin 8699 L850020r0217 Tindamax 500mg 20ct Label Fnl2 Vp

Tin 8699 L850020r0217 Tindamax 500mg 20ct Label Fnl2 Vp
Label for Tindamax 500 mg film-coated tablets, containing tinidazole, manufactured by Mission Pharmacal Company. The label shows a package size of 20 tablets with the NDC 0178-8500-20. It includes storage instructions to keep at controlled room temperature (20-25°C, 68-77°F) and notes the product is Rx only.*
FDA Label Image

Table

Table
A data table showing the percentages of patients experiencing various treatment-emergent adverse reactions during Tindamax therapy. It compares the incidence of each reaction between the 2 g single dose and the multi-day dose, including symptoms such as metallic/bitter taste, nausea, anorexia, dyspepsia/cramps/epigastric discomfort, vomiting, constipation, CNS weakness/drowsiness/malaise, dizziness, headache, and others, along with total patients with adverse reactions.*
FDA Label Image

Struct-tinidazole (Tindamax Image01)

Struct-tinidazole (Tindamax Image01)
Chemical structure diagram of tinidazole, the active ingredient in Tindamax tablets. The structure shows the molecular arrangement including nitrogen, oxygen, sulfur atoms, and an ethylsulfonyl ethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.